← All stacks
Fat Loss

CagriSema

Also known as: Cagrilintide + Semaglutide, Cagri/Sema

A combination of a long-acting amylin analog with a GLP-1 agonist to enhance satiety and appetite suppression for weight loss.

Components

How it's combined

In clinical research, CagriSema (Novo Nordisk) pairs cagrilintide (amylin analog acting on hindbrain satiety) with semaglutide (GLP-1 agonist) for additive appetite reduction; it is the combination with published human trial data among amylin pairings. Once-weekly subcutaneous in trial settings. Investigational as a combination.

Available from vendors

PeptideChat is an independent research resource, not the seller. Links go to third-party vendors; products are sold strictly as research chemicals and are not intended for human consumption.

Peptide ClubCagrilintide · from $37.99Peptide ClubGLP-1 S · from $22.99

  • Independent research resource

    Not a seller — PeptideChat doesn't sell or ship products.

  • Research-use-only framing

    Content is educational, not a dosing recommendation.

  • Vendor links clearly disclosed

    Outbound links to third-party vendors are always labeled.

Research framing only. Stacks are described as they appear in research and biohacking literature. Nothing here is medical advice or a dosing protocol; these peptides are sold as research chemicals and are not approved for human use. Always consult a licensed healthcare provider.
Ask PeptideChat about this stackBrowse all peptides

PeptideChat is for educational and research purposes only. Nothing on this site constitutes medical advice. Peptides are sold as research chemicals only and are not intended for human use. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. PeptideChat is an independent educational resource — not a pharmacy, compounding, or 503A/503B outsourcing facility — and does not sell products or provide medical advice.